Abrdn PLC Novo Cure LTD Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$16.15 - $42.35 $146,771 - $384,876	-9,088 Reduced 20.01%	36,339 $586,000
Q2 2023 Jun 20, 2024	BUY	$40.29 - $82.51 $67,364 - $137,956	1,672 Added 3.82%	45,427 $1.89 Million
Q2 2023 Aug 04, 2023	BUY	$40.29 - $82.51 $67,364 - $137,956	1,672 Added 3.82%	45,427 $1.89 Million
Q1 2023 Jun 20, 2024	BUY	$56.44 - $118.81 $606,504 - $1.28 Million	10,746 Added 32.55%	43,755 $2.63 Million
Q1 2023 Apr 28, 2023	BUY	$56.44 - $118.81 $606,504 - $1.28 Million	10,746 Added 32.55%	43,755 $2.63 Million
Q4 2022 Jun 20, 2024	BUY	$63.98 - $85.37 $2.11 Million - $2.82 Million	33,009 New	33,009 $2.42 Million
Q4 2022 Feb 09, 2023	BUY	$63.98 - $85.37 $82,534 - $110,127	1,290 Added 4.07%	33,009 $2.42 Million
Q3 2022 Nov 10, 2022	BUY	$67.99 - $89.57 $712,127 - $938,156	10,474 Added 49.3%	31,719 $2.41 Million
Q2 2022 Aug 05, 2022	BUY	$56.6 - $89.9 $131,595 - $209,017	2,325 Added 12.29%	21,245 $1.48 Million
Q1 2022 May 04, 2022	BUY	$60.15 - $84.52 $216,239 - $303,849	3,595 Added 23.46%	18,920 $1.57 Million
Q4 2021 Feb 08, 2022	BUY	$75.08 - $121.99 $64,493 - $104,789	859 Added 5.94%	15,325 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $352,575 - $590,459	3,035 Added 26.55%	14,466 $1.68 Million
Q2 2021 Aug 10, 2021	SELL	$130.4 - $225.58 $298,094 - $515,675	-2,286 Reduced 16.67%	11,431 $2.54 Million
Q1 2021 May 06, 2021	BUY	$124.11 - $190.17 $1 Million - $1.54 Million	8,072 Added 142.99%	13,717 $1.81 Million
Q4 2020 Feb 10, 2021	BUY	$112.16 - $174.14 $137,956 - $214,192	1,230 Added 27.86%	5,645 $978,000
Q3 2020 Oct 21, 2020	BUY	$58.05 - $111.31 $256,290 - $491,433	4,415 New	4,415 $492,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$205 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$200 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$134 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$72.6 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$51.1 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account